Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.8B | 9.4B | 9.9B | 8.7B |
Cost of revenue | 3.9B | 4.2B | 4.4B | 3.8B |
Gross profit | 4.9B | 5.1B | 5.5B | 4.9B |
Operating expense | ||||
Research & development | 1.9B | 1.9B | 1.9B | 2.0B |
Selling general and admin | 657.0M | 601.7M | 616.1M | 648.5M |
Other operating expenses | — | — | — | — |
Operating income | 2.4B | 2.7B | 3.0B | 2.2B |
Non operating interest income | ||||
Income | 136.4M | 142.3M | 144.0M | 157.7M |
Expense | 143.2M | 138.9M | 138.9M | 153.4M |
Other income expense | 168.7M | -16.2M | 63.1M | 47.7M |
Pretax income | 2.5B | 2.6B | 3.1B | 2.2B |
Tax provision | 243.7M | 249.7M | 387.8M | -271.9M |
Net income | 2.3B | 2.4B | 2.7B | 2.5B |
Basic EPS | 2.4 | 2.6 | 2.9 | 2.6 |
Diluted EPS | 2.4 | 2.5 | 2.8 | 2.6 |
Basic average shares | 930.6M | 940.8M | 945.9M | 950.2M |
Diluted average shares | 936.6M | 950.2M | 956.2M | 962.1M |
EBITDA | 2.9B | 3.1B | 3.6B | 2.7B |
Net income from continuing op. | 2.3B | 2.4B | 2.7B | 2.5B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |